Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS)

BACKGROUND: Subcutaneous administration of Eprex(®) (epoetin alfa) in patients with chronic kidney disease (CKD) was contraindicated in the European Union between 2002 and 2006 after increased reports of anti-erythropoietin antibody-mediated pure red cell aplasia (PRCA). The Prospective Immunogenici...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nephrol Dial Transplant
Main Authors: Macdougall, Iain C., Casadevall, Nicole, Locatelli, Francesco, Combe, Christian, London, Gerard M., Di Paolo, Salvatore, Kribben, Andreas, Fliser, Danilo, Messner, Hans, McNeil, John, Stevens, Paul, Santoro, Antonio, De Francisco, Angel L.M., Percheson, Paul, Potamianou, Anna, Foucher, Arnaud, Fife, Daniel, Mérit, Véronique, Vercammen, Els
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
CLINICAL SCIENCE
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4339685/
https://ncbi.nlm.nih.gov/pubmed/25239637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfu297
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados